Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis | C564570 | |
| Lung Injury | D055370 | [Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES.] |
| Thoracic Injuries | D013898 | [General or unspecified injuries to the chest area.] |
| Lung Diseases | D008171 | [Pathological processes involving any part of the LUNG.] |
| Acute Lung Injury | D055371 | [A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).] |
| AMP-Activated Protein Kinases | D055372 | [Intracellular signaling protein kinases that play a signaling role in the regulation of cellular energy metabolism. Their activity largely depends upon the concentration of cellular AMP which is increased under conditions of low energy or metabolic stress. AMP-activated protein kinases modify enzymes involved in LIPID METABOLISM, which in turn provide substrates needed to convert AMP into ATP.] |
| Protein-Serine-Threonine Kinases | D017346 | [A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors.] |
| Intracellular Signaling Peptides and Proteins | D047908 | [Proteins and peptides that are involved in SIGNAL TRANSDUCTION within the cell. Included here are peptides and proteins that regulate the activity of TRANSCRIPTION FACTORS and cellular processes in response to signals from CELL SURFACE RECEPTORS. Intracellular signaling peptide and proteins may be part of an enzymatic signaling cascade or act through binding to and modifying the action of other signaling factors.] |
| 3-(3-(4-methoxyphenyl)quinolin-2-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | C000605650 | |
| D-Worm | C000605651 | |
| poly(2,7-(9,9-dihexyl)fluorene) | C000605652 | |
| piscroside C | C000605653 | |
| Adrenal Hypoplasia, Congenital, with Precocious Puberty | C564568 | |
| asperulosidic acid | C432744 | |
| anticoagulation factor II, Agkistrodon acutus | C432745 | |
| TXKS1, Buthus martensii | C432746 | |
| 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC | C432747 | |
| Mental Retardation, X-Linked, Syndromic 10 | C564560 | |
| Myotubular Myopathy with Abnormal Genital Development | C564561 | |
| Lissencephaly, X-Linked, 2 | C564563 |